Literature DB >> 15478945

Ciprofloxacin-induced glutathione redox status alterations in rat tissues.

Aylin Gürbay1, Filiz Hincal.   

Abstract

The possible oxidative stress inducing effect of a fluoroquinolone (FQ) antibiotic, ciprofloxacin (CPFX), was investigated in rats measuring glutathione redox status. For this purpose, the drug was administered to rats as two different single doses (100 and 150 mg/kg, ip) or a repeated dose (500 mg/kg/d, ig, for 5d). Then, total and oxidized glutathione levels were determined in hepatic and cerebral tissues of the rats by an enzymatic cycling assay, and the glutathione redox status was calculated. The possible protective effects of vitamin E or allopurinol against CPFX-induced alterations on glutathione system have also been examined. Following both routes of administration of CPFX, the total glutathione content of the liver, but not of brain decreased significantly. The oxidized glutathione (GSSG) in the brain increased after single or repeated dose treatments, but only with repeated doses of CPFX in the liver. CPFX induced dose-dependent alterations in the glutathione redox status in both tissues. With single doses the effect was more pronounced in cerebral tissue, and with repeated ig doses it was significant in both tissues. Pretreatment of rats with vitamin E or allopurinol before the administration of CPFX provided marked protection against glutathione redox status alterations in both tissues. Our results, thus, indicate that CPFX treatment introduces an oxidative stress in cerebral and hepatic tissues of rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478945     DOI: 10.1081/dct-120037504

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  14 in total

1.  Daily ciprofloxacin treatment for patients with advanced liver disease awaiting liver transplantation reduces hospitalizations.

Authors:  G Y Minuk; K Hawkins; K D E Kaita; S Wong; E Renner; L Minuk; J Uhanova
Journal:  Dig Dis Sci       Date:  2010-11-06       Impact factor: 3.199

2.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

3.  Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C.

Authors:  Majed M Masadeh; Nizar M Mhaidat; Karem H Alzoubi; Sayer I Al-Azzam; Ashraf I Shaweesh
Journal:  Curr Microbiol       Date:  2012-02-18       Impact factor: 2.188

4.  The effect of ciprofloxacin on doxorubicin cytotoxic activity in the acquired resistance to doxorubicin in DU145 prostate carcinoma cells.

Authors:  Asieh Davary Avareshk; Jamileh Gholami; Razieh Jalal
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

5.  Fluoroquinolones lower constitutive H2AX and ATM phosphorylation in TK6 lymphoblastoid cells via modulation of the intracellular redox status.

Authors:  H Dorota Halicka; Daniel J Smart; Frank Traganos; Gary M Williams; Zbigniew Darzynkiewicz
Journal:  Pharmacol Rep       Date:  2009 Jul-Aug       Impact factor: 3.024

6.  Effects of repeated oral administration of pazufloxacin mesylate and meloxicam on the antioxidant status in rabbits.

Authors:  Adil Mehraj Khan; Satyavan Rampal
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-07       Impact factor: 1.232

7.  Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters.

Authors:  Nadia M S Arafa; Mona Abdel-Rahman; Manal F El-khadragy; Rami B Kassab
Journal:  Neurochem Res       Date:  2012-10-21       Impact factor: 3.996

8.  CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever.

Authors:  Sean R Marcsisin; Xiannu Jin; Theresa Bettger; Nicholas McCulley; Jason C Sousa; G Dennis Shanks; Babu L Tekwani; Rajnish Sahu; Gregory A Reichard; Richard J Sciotti; Victor Melendez; Brandon S Pybus
Journal:  Malar J       Date:  2013-06-21       Impact factor: 2.979

9.  Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors.

Authors:  Majed M Masadeh; Karem H Alzoubi; Omar F Khabour; Sayer I Al-Azzam
Journal:  Curr Ther Res Clin Exp       Date:  2014-12-05

10.  Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents.

Authors:  Majed M Masadeh; Karem H Alzoubi; Sayer I Al-Azzam; Omar F Khabour; Ahlam M Al-Buhairan
Journal:  Pathogens       Date:  2016-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.